Mountcastle David sold $433K of PRVA
Mountcastle David (EVP & Chief Financial Officer) sold 17,196 shares of Privia Health Group, Inc. (PRVA) at $25.18 ($0.43M total) on 2026-06-26 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed open-market sale by the CFO under a 10b5-1 plan is generally treated as routine and not a fundamental change signal by itself.
Market read
Traders may note the disclosure for sentiment/positioning, but it is unlikely to drive a major repricing without additional fundamental news.
What to watch
The article provides only the sale details; it does not state whether there were concurrent buys, option exercises, or broader insider activity trends.
Background
The article is an SEC Form 4 insider transaction disclosure for Privia Health Group, Inc.
Ticker impact
Privia Health Group CFO David Mountcastle sold 17,196 shares in an open-market transaction under a 10b5-1 plan, totaling about $433K.
Low likelihood of a sustained price move solely from this Form 4 sale; any impact would be sentiment-driven and short-lived.
The filing is a Form 4 insider sale with explicit 10b5-1 pre-arrangement, which reduces the informational content versus discretionary selling.
Market effects
Minimal—this is company-specific insider activity with no sector-wide catalyst described.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can still coincide with management’s view of valuation or liquidity needs; traders may watch for clustering of sales.
Key entities
- issuerPrivia Health Group, Inc.
Subject of the Form 4 insider transaction; CFO David Mountcastle sold shares totaling ~$432,995.28.
- insiderDavid Mountcastle
EVP & Chief Financial Officer who executed the open-market sale under a pre-arranged 10b5-1 plan.
